Overview

ALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Patients With a 1st Episode Due to BPH

Status:
Completed

Trial end date:
2004-10-01

Target enrollment:

Participant gender:

Summary

To assess the efficacy of alfuzosin 10mg OD in the management of acute urinary retention associated with BPH. To assess the safety of alfuzosin in this population and health care consumption.

Phase:

Phase 3

Details

Lead Sponsor:

Sanofi

Treatments:

Alfuzosin